13 countries in Africa unite to find a potential COVID-19 treatment
Category: #health  By Saipriya Iyer  Date: 2020-11-26
  • share
  • Twitter
  • Facebook
  • LinkedIn

13 countries in Africa unite to find a potential COVID-19 treatment

Thirteen African nations have joined hands with researchers across the world to rollout the largest clinical study of potential coronavirus treatments on the African continent.

The trial, dubbed the Anticov study, involves contributions from international research institutions and Antwerp’s Institute of Tropical Medicine. This study aims to find potential treatments that can be utilized for the treatment of moderate and mild COVID-19 positive patients and prevent the hospitals from being overwhelmed, ensuring that the region’s fragile and overburdened healthcare systems does not fall apart.

The clinical study would take place across 19 sites located in 13 different nations and would be led by different doctors from Africa. The initiative came to fruition after calls were made for responses to the COVID-19 that are better designed for the developing world and the challenges of generally underfunded healthcare systems.

Director, African Centers for Disease Control and Prevention, Dr. John Nkengasong stated that large clinical trials for coronavirus are needed in Africa to answer research questions particular to the African context.

So far, many African nations have contained this rapidly spreading disease from affecting its citizens and now it is the time for these nations to be ready for next waves of this disease. It would help resolve one of the most critical questions: Given the limited number of ICU facilities in the continent, can Africa treat people for coronavirus earlier and prevent hospitals from being swamped?

The clinical study would assess the efficacy of the treatment within across 2,000 to 3,000 mild COVID-19 patients across 13 countries, including Uganda, Sudan, Mozambique, Mali, Kenya, Guinea, Ghana, Ethiopia, Equatorial Guinea, the Democratic Republic of the Congo, Ivory Coast, Cameroon, and Burkina Faso.

The primary aim would be to identify treatments that would stop COVID-19 from developing into a severe disease as well as reduce the rate of transmission. It will be an adaptive platform study, a innovative kind of clinical study engineered for cancer drugs that allow various treatments to be tested simultaneously.

Source credit: https://www.theguardian.com/global-development/2020/nov/24/africas-largest-covid-treatment-clinical-trial-launched-by-13-country-network



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

EU starts mass COVID-19 vaccination program in 27 member-states
EU starts mass COVID-19 vaccination program in 27 member-states
By Saipriya Iyer

The European Union has recently started a mass COVID-19 vaccination campaign to inoculate over 450 million individuals in 27 member-states.

EU leaders have reportedly negotiated var...

Asus announces plans to strengthen its offline retail presence in India
Asus announces plans to strengthen its offline retail presence in India
By Saipriya Iyer

AsusTek Computer Inc., popularly known as Asus, has reportedly announced plans to strengthen its offline retail presence across India. The firm, which had 7.5% of total market share in the Indian PC segment in the Q3 o...

Need for efficient sea vessels to augment marine turbocharger deployment
Need for efficient sea vessels to augment marine turbocharger deployment
By Saipriya Iyer

Increasing globalization and the subsequent rise in seaborne trade activities are fueling the global marine turbochargers industry size. These trends have created a significant demand for commercial vessels. Growth of ...